Opthea Ltd
(ASX:OPT)
A$
0.825
0.005 (0.61%)
Market Cap: 1.02 Bil
Enterprise Value: 968.84 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 17/100 Opthea Ltd Key Opinion Leader Event On Sozinibercept In Wet Age Related Macular Degeneration Presentation Transcript
Apr 02, 2024 / 11:00PM GMT
Release Date Price:
A$0.690791
(+1.35%)
Operator
Presentation
Apr 02, 2024 / 11:00PM GMT
=====================
Corporate Participants
=====================
* Fred Guerard
Opthea Limited, Inc. - CEO
* Arshad Khanani
Opthea Limited, Inc. - CMO
* Charles Wykoff
Opthea Limited, Inc. - Chief Investigator for COAST
* Veeral Sheth
Opthea Limited, Inc. - Principal Investigator for ShORe
=====================
Conference Call Participants
=====================
* Matthew Caulfield
H.C. Wainwright & Co.,LLC - Analyst
* Bosma Rodwin
Leerink Partners, LLC - Analyst
* Hartaj Singh
Oppenheimer & Co., Inc. - Analyst
* Clara Dong
Jefferies Financial Group, Inc. - Anayst
* Asheikh Mubarak
Citigroup, Inc. - Analyst
=====================
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot